1976
DOI: 10.1246/cl.1976.987
|View full text |Cite
|
Sign up to set email alerts
|

The SYNTHESIS OF Α,γ-Dinucleoside TRIPHOSPHATES. THE CONFRONTED NUCLEOTIDE STRUCTURE FOUND AT THE 5′-Terminus OF EUKARYOTE MESSENGER RIBONUCLEIC ACID

Abstract: α,γ-Dinucleoside triphosphates showing the recently discovered modified structure at the 5′-terminus of eukaryote mRNA were synthesized by use of a new method employing di-n-butylphosphinothioyl bromide.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

1977
1977
2014
2014

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 13 publications
0
5
0
Order By: Relevance
“…Eukaryotic mRNAs have a cap structure (m7G5'pppNNN...) at their 5'-terminus. This structure was first found by Miura (1) in 1975 from cytoplasmic polyhedrosis virus and the structure was confirmed by its chemical synthesis (2)(3)(4)(5). This cap structure is known to act in the important role of binding mRNAs to ribosome (6-8) and for the stabilization of mRNAs against 5'-exonucleases (9,10).…”
Section: Introductionmentioning
confidence: 85%
See 1 more Smart Citation
“…Eukaryotic mRNAs have a cap structure (m7G5'pppNNN...) at their 5'-terminus. This structure was first found by Miura (1) in 1975 from cytoplasmic polyhedrosis virus and the structure was confirmed by its chemical synthesis (2)(3)(4)(5). This cap structure is known to act in the important role of binding mRNAs to ribosome (6-8) and for the stabilization of mRNAs against 5'-exonucleases (9,10).…”
Section: Introductionmentioning
confidence: 85%
“…ammonia as shown in Scheme I. For the construction of the cap structure at its 5'-terminus, it was converted into the phosphorimidazolide (3) and reacted with the capping agent (ppm7GTMTrmM) (4). Finally, whole protecting groups were removed under acidic conditions to afford the capped 9-mer, m7G5'pppGUAUUAAUA (5, F-1).…”
Section: }1mentioning
confidence: 99%
“…The organic extracts were combined, dried over sodium sulfate, and concentrated in vacuo. The residue was chromatographed on silica gel column (ethyl acetate) to afford MMTrAZ (1.10 g, 60%): NMR(CDC13),'3.52(3H, s, 2'-O-CH3), 3.77(3H, 9.96%. To a mixture of MWTrAlz (146 mg, 0.22 mmol) and cyclohexylammonium S,S-di-4-methoxyphenyl phosphorodithioate (1.19 g, 0.27 mmol) in dry pyridine (1 ml) was added TPS (160 mg, 0.53 mmol) and the solution was stirred at room temperature for 3 days.…”
Section: N-benzoyl-2'-o-methyladenosine (Az)mentioning
confidence: 99%
“…It is to be noted that mRNAs possessing correctly incorporated caps, i.e., m 7 G [5 ] [11]. Although the synthetic conventional cap analog, m 7 G[5 ]ppp [5 ]N has been known for the last three decades [12], the first syntheses of cap analogs with 3 -OH modification on m 7 G moiety such as m 2 [5 ]G and m 7 3 dG [5 ]ppp [5 ]G were reported by Stepinski et al in 2001 [13]. It is noteworthy that these analogs are incorporated exclusively in the forward orientation and the reverse orientation is not possible because of the absence of free 3 -OH group on m 7 G moeity and these analogs are called "antireverse" cap analogs (ARCA) [13,14].…”
Section: Introductionmentioning
confidence: 99%